Sign in Subscribe
Vaccines

Multiple COVID-19 Vaccines in Development as Infection Rate Surpasses 2.7 Million

Strategic Insights

— 1 min read

Global efforts to combat the COVID-19 pandemic have accelerated with the World Health Organization (WHO) reporting six novel coronavirus vaccines in clinical trials. Oxford University has joined the list of vaccine candidates published by the WHO, alongside Moderna Inc., Inovio Pharmaceuticals Inc., and Chinese companies Sinovac, CanSino Biological Inc., and Beijing Institute of Biological Products. The rapid development of coronavirus vaccines is driven by the urgent need to contain the spread of the virus, which has infected over 2.7 million people and claimed 190,858 lives worldwide, according to Johns Hopkins University data.

Key Takeaways:

  • Six novel coronavirus vaccines are in clinical trials, with Oxford University being the latest entrant.
  • The WHO has listed 77 additional coronavirus vaccines in preclinical stages, including those developed by Novavax, Inc., Vaxart Inc., and several universities.
  • Researchers at Oxford University aim to make their vaccine available at mass scale starting September if successful in clinical trials.
  • The rapid development of vaccines is driven by the urgency of containing the pandemic, with over 2.7 million people infected and 190,858 deaths worldwide.
  • Several companies, including Moderna Inc. and Inovio Pharmaceuticals Inc., have already begun clinical trials in the United States.
  • Johnson & Johnson has announced plans to start clinical trials by the end of this year.
  • The development process is expected to be accelerated, with Anthony Fauci, a lead member of the White House Coronavirus Task Force, predicting a vaccine could be available within 12 to 18 months.

Statistics:

  • Over 2.7 million people have been infected with the virus worldwide.
  • 190,858 people have died from COVID-19 globally.
  • 6 coronavirus vaccines are currently in clinical trials.
  • 77 coronavirus vaccines are in preclinical stages.
  • 12-18 months is the predicted time frame for vaccine development, according to Anthony Fauci.
  • Clinical trials have already begun for several companies, including Moderna Inc. and Inovio Pharmaceuticals Inc.

Sources:

  • The World Health Organization (WHO)
  • Johns Hopkins University
  • Legal Monitor Worldwide
  • SyndiGate Media Inc.

Read more